Denavir and Triamcinolone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Denavir (penciclovir sodium) and Triamcinolone (triamcinolone). Common drug interactions include chronic kidney disease among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Denavir and Triamcinolone. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Denavir?

Denavir has active ingredients of penciclovir sodium. eHealthMe is studying from 570 Denavir users. Check the latest studies of Denavir.

What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 25,577 Triamcinolone users. Check the latest studies of Triamcinolone.



On Jul, 13, 2026

18 people who take Denavir and Triamcinolone together, and have interactions are studied.

Denavir and Triamcinolone drug interactions.

What are the common drug interactions of Denavir and Triamcinolone, by gender? *:

female:

  1. Chronic kidney disease
  2. Foot deformity (functional disability of foot)
  3. Foot fracture
  4. Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
  5. Injury
  6. Nephropathy (damage to or disease of a kidney)
  7. Renal failure (kidney dysfunction)
  8. Abdominal pain
  9. General physical health deterioration (weak health status)
  10. Infection

male:

  1. Renal failure (kidney dysfunction)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Bone density decreased
  5. Emotional distress
  6. Multiple fractures
  7. Pain
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Chronic kidney disease
  10. Nephropathy (damage to or disease of a kidney)

What are the common drug interactions of Denavir and Triamcinolone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anxiety
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Emotional distress
  4. General physical health deterioration (weak health status)
  5. Injury
  6. Pain
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Pulmonary infarction (death of a small area of lung)

20-29:

  1. Cardiac disorder
  2. Migraine (headache)
  3. Type 1 diabetes mellitus
  4. Abdominal pain upper
  5. Cardiac failure congestive
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Diarrhoea
  8. Encephalitis (inflammation of the brain)
  9. Gastritis (inflammation of stomach)
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

30-39:

n/a

40-49:

  1. Abdominal pain
  2. General physical health deterioration (weak health status)
  3. Infection
  4. Injury
  5. Uterine perforation (accidental puncture of the uterus)
  6. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)

50-59:

  1. Renal failure (kidney dysfunction)
  2. Osteopenia (a condition where bone mineral density is lower than normal)
  3. Encephalitis (inflammation of the brain)
  4. Precancerous skin lesion
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Bone density decreased
  8. Emotional distress
  9. Multiple fractures
  10. Pain

60+:

  1. Chronic kidney disease
  2. Nephropathy (damage to or disease of a kidney)
  3. Renal failure (kidney dysfunction)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the existing conditions these people have? *

  1. Pain: 9 people, 50.00%
  2. High Blood Cholesterol: 9 people, 50.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 38.89%
  4. Depression: 7 people, 38.89%
  5. High Blood Pressure: 7 people, 38.89%
  6. Nausea (feeling of having an urge to vomit): 6 people, 33.33%
  7. Stress And Anxiety: 6 people, 33.33%
  8. Infection: 6 people, 33.33%
  9. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 27.78%
  10. Skin Disorder (skin disease): 5 people, 27.78%

* Approximation only. Some reports may have incomplete information.

Do you take Denavir and Triamcinolone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Denavir and Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Denavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Denavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triamcinolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on penciclovir sodium and triamcinolone (the active ingredients of Denavir and Triamcinolone, respectively), and Denavir and Triamcinolone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: